Goldman Sachs Removed Aetna (AET) from its Conviction Sell List
More News related to AET
- Delaware Physicians Care Named One of Top Medicaid Plans In the Nation by U.S. News & World Report/ NCQA
- New Agreement for Hartford Healthcare and Aetna
- Aetna (AET) volatility low into Senate health reform bill and analyst meeting
- Aetna Inc. (AET) cutting 625 jobs. To see $40M charge
- Aetna Announces Targeted Job Eliminations
More News related to Analyst Comments
- Strategist Says $1500/oz Gold Will Lead Oil Above $100/bbl
- Analysts Bullish on Analog Devices (ADI) Following Q4 Results: AmTech, GC Research Upgrade, Citi Lifts Price Target
- UBS Raises Estimates and Price Target on Wal-Mart (WMT)
- Susquehanna Maintains a 'Positive' Rating on Hewlett-Packard (HPQ); Raises PT to $58
- Credit Suisse Maintains an 'Outperform' on Newmont Mining (NEM), Raises PT
Goldman Sachs removed Aetna (NYSE: AET) from its Conviction Sell List, although the firm is maintaining its Sell rating and $23 price target. The move follows yesterday's lower-than-expected earnings and lower guidance from the health insurer. Goldman said the view is that Aetna has now sufficiently lowered the bar such that 2nd-half EPS forecast is achievable.
Aetna Inc. operates as a diversified health care benefits company primarily in the United States.
Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
Analyst CommentsStocks Mentioned
+0.28Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
